IACA is honored to announce this year’s recipient of IACA Award for Outstanding Contributions to Oncology is Dr. Ravi Salgia. Dr. Salgia is also the keynote speaker at the IACA annual meeting at ASCO 2017.
When: Saturday, June 3rd 2017 at 6:30 PM
Where: Westin Michigan Avenue
909 North Michigan Avenue
Chicago, IL 60611
An esteemed physician and translational researcher, Ravi Salgia M.D., Ph.D., is the Arthur & Rosalie Kaplan Chair in Medical Oncology
and Therapeutics Research at City of Hope, and the associate director for clinical sciences in City of Hope’s Comprehensive Cancer Center
Dr. Salgia has over 25 years of experience in translational research and the development of targeted therapies to improve the quality of life and survival of cancer patients, especially as related to small cell lung cancer. Dr.Salgia was the first to clone the focal adhesion protein paxillin and also localize the gene to 12q24. His laboratory also identified the gain-of-function mutations of paxillin in lung cancer. He went on to define receptor tyrosine kinases and have identified unique targets in lung cancer such as MET/RON and EPHB4 receptor tyrosine kinases. In fact his laboratory elucidated the exon 14 skipping of MET in small cell lung cancer and non-small cell lung cancer that has treatment implications in EGFR mutation lung cancer. His group have also developed a large bioinformatics database for thoracic oncology. He has authored over 330 peer-reviewed articles, reviews and editorials, one book, and 34 book chapters, and has been awarded several NIH grants for his research, as well as several invention discoveries and patents related to his work. He is the current Chief Editor for Cancer Commons, and Associate Editor for a number of journals. He is internationally known for his scientific accomplishments, and serves as a chartered member of NIH/NCI’s Clinical Oncology Study Section, was elected as the Translational Science Representative on the Thoracic Malignancy Steering Committee of the NCI, and previously served on the NIH Tumor Progression and Metastasis Study Section. At the City of Hope he has developed a large informatics database in thoracic malignancies that is available on the iBridge network.
Prior to joining City of Hope, Dr. Salgia served as tenured professor of medicine, pathology and dermatology; director of the Thoracic Oncology Program and the Aerodigestive Tract Program Translational Research Lab in the section of hematology/oncology; and vice chair for translational research in the department of medicine at the University of Chicago. He was also associate director for translational science at the University of Chicago Comprehensive Cancer Center in Chicago.
Past recipients of this Outstanding Award in Oncology have included Dr. Manjit Singh Bains, Dr. Jatin Shah, Dr. Mansukh Wani, and Dr. Rengaswamy Sankaranarayanan. We hope you join us this year to honor another deserving oncologist and take part in hearing his incredible story.
While you are at ASCO 2017, also come visit us at our Booth #5035 in the Exhibit Hall